Skip to Content

Paragon 28 Inc FNA

Morningstar Rating
$10.05 +0.26 (2.66%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FNA is trading at a 28% discount.
Price
$9.81
Fair Value
$24.33
Uncertainty
Very High
1-Star Price
$12.23
5-Star Price
$9.49
Economic Moat
Kzlmc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FNA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$9.79
Day Range
$9.7510.18
52-Week Range
$7.9519.72
Bid/Ask
$9.62 / $12.57
Market Cap
$833.21 Mil
Volume/Avg
374,927 / 538,485

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.66
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
574

Comparables

Valuation

Metric
FNA
ZIMV
MMSI
Price/Earnings (Normalized)
9.8424.65
Price/Book Value
4.501.063.57
Price/Sales
3.660.933.44
Price/Cash Flow
12.4820.12
Price/Earnings
FNA
ZIMV
MMSI

Financial Strength

Metric
FNA
ZIMV
MMSI
Quick Ratio
2.220.843.81
Current Ratio
4.212.785.45
Interest Coverage
−8.22−1.518.07
Quick Ratio
FNA
ZIMV
MMSI

Profitability

Metric
FNA
ZIMV
MMSI
Return on Assets (Normalized)
−11.27%14.12%9.43%
Return on Equity (Normalized)
−18.48%31.63%14.77%
Return on Invested Capital (Normalized)
−12.43%18.79%11.47%
Return on Assets
FNA
ZIMV
MMSI
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesCvfcjdjcwPqbjcgp$185.8 Bil
SYK
Stryker CorpHcbqbnqqBrlz$127.4 Bil
MDT
Medtronic PLCDlrrhfylTnmvhm$105.2 Bil
BSX
Boston Scientific CorpBbfzpwrgQgfjwjt$99.0 Bil
DXCM
DexCom IncWntvdglvbdZvjy$53.1 Bil
EW
Edwards Lifesciences CorpCtnfzhyhNlggnvw$52.8 Bil
ZBH
Zimmer Biomet Holdings IncCrksdndcjtTcj$25.0 Bil
ALGN
Align Technology IncTvfssgbfRnzqfgj$23.5 Bil
PHG
Koninklijke Philips NV ADRYscytnsryLnjckw$18.5 Bil
PODD
Insulet CorpTxsyfdjzrBwylfm$11.7 Bil

Sponsor Center